Literature DB >> 8382134

Possible link between vitamin D and hyperoxaluria in patients with renal stone disease.

S Giannini1, M Nobile, R Castrignano, T Pati, A Tasca, G Villi, F Pellegrini, A D'Angelo.   

Abstract

1. Vitamin D seems to play an essential role in the pathogenesis of idiopathic hypercalciuria at least in part via intestinal hyperabsorption of calcium. Hyperabsorption of calcium, in turn, might enhance the intestinal uptake of free oxalate, thus leading to hyperoxaluria. To verify this hypothesis we studied 75 calcium-stone-formers subdivided as follows: group 1 (15 patients) with isolated hyperoxaluria; group 2 (25 patients) with hyperoxaluria and hypercalciuria; group 3 (22 patients) with isolated hypercalciuria; group 4 (12 patients) with no metabolic abnormalities. 2. As expected, urinary calcium excretion differed in the various groups (P < 0.001), being highest in groups 2 and 3; urinary oxalate excretion, by definition highest in groups 1 and 2, was even more pronounced in group 2 than in group 1 (P < 0.05). Although in the normal range, the serum 1,25-dihydroxyvitamin D concentration was higher (P < 0.001) in the two hypercalciuric groups (2 and 3), showing peak levels in group 2. 3. When the data from the 75 stone-formers were pooled, there was a positive correlation between the serum concentration of 1,25-dihydroxyvitamin D and urinary calcium excretion (P < 0.001) and urinary oxalate excretion (P < 0.003), the latter relationship also being present when only the two hypercalciuric groups (groups 2 and 3) were considered together (P < 0.05). 4. Our data seem to confirm a relevant role for the vitamin D system in the pathogenesis of calcium nephrolithiasis due to increased intestinal calcium absorption, but also because this in turn induces a greater intestinal absorption of oxalate, thus leading to the occurrence or exacerbation of hyperoxaluria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382134     DOI: 10.1042/cs0840051

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

1.  Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.

Authors:  C P Williams; D F Child; P R Hudson; G K Davies; M G Davies; R John; P S Anandaram; A R De Bolla
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Idiopathic hypercalciuria: O2(-)NO relationship and altered bone metabolism.

Authors:  L Calò; S Giannini; P Bonvicini; M Nobile; S Cantaro; M Plebani; A Semplicini; A D'Angelo; G Crepaldi
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

3.  Risk factors associated to kidney stones in primary hyperparathyroidism.

Authors:  S Corbetta; A Baccarelli; A Aroldi; L Vicentini; G B Fogazzi; C Eller-Vainicher; C Ponticelli; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

4.  An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.

Authors:  Nasser Shakhssalim; Kobra Roohi Gilani; Mahmoud Parvin; Peyman Mohammadi Torbati; Amir H Kashi; Mohaddeseh Azadvari; Banafsheh Golestan; Abbas Basiri
Journal:  Urol Res       Date:  2010-05-19

5.  Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?

Authors:  C P Williams; D F Child; P R Hudson; L D Soysa; G K Davies; M G Davies; A R De Bolla
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

6.  Association of urinary calcium excretion with serum calcium and vitamin D levels.

Authors:  Anita Rathod; Olivier Bonny; Idris Guessous; Paolo M Suter; David Conen; Paul Erne; Isabelle Binet; Luca Gabutti; Augusto Gallino; Franco Muggli; Daniel Hayoz; Antoinette Péchère-Bertschi; Fred Paccaud; Michel Burnier; Murielle Bochud
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-17       Impact factor: 8.237

7.  Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women.

Authors:  Kristina L Penniston; Andrea N Jones; Stephen Y Nakada; Karen E Hansen
Journal:  BJU Int       Date:  2009-04-15       Impact factor: 5.588

Review 8.  Association between Circulating Vitamin D Level and Urolithiasis: A Systematic Review and Meta-Analysis.

Authors:  Henglong Hu; Jiaqiao Zhang; Yuchao Lu; Zongbiao Zhang; Baolong Qin; Hongbin Gao; Yufeng Wang; Jianning Zhu; Qing Wang; Yunpeng Zhu; Yang Xun; Shaogang Wang
Journal:  Nutrients       Date:  2017-03-18       Impact factor: 5.717

9.  1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.

Authors:  René Rodríguez-Gutiérrez; Maria Azucena Zapata-Rivera; Dania Lizeth Quintanilla-Flores; Carlos Rodrigo Camara-Lemarroy; Fernando Javier Lavalle-Gonzalez; José Gerardo González-González; Jesús Zacarías Villarreal-Pérez
Journal:  BMC Endocr Disord       Date:  2014-04-10       Impact factor: 2.763

10.  Association between serum vitamin D levels and the risk of kidney stone: evidence from a meta-analysis.

Authors:  Hai Wang; Libo Man; Guizhong Li; Guanglin Huang; Ning Liu
Journal:  Nutr J       Date:  2016-03-31       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.